Bone cancer, Children's cancers, Ewing sarcoma, Sarcoma, Soft tissue sarcoma
Results
Phase 3
This trial looked at a new drug called deforolimus (also called ridaforolimus) to find out if it could control the growth of a type of cancer called sarcoma. It was for people who had soft tissue sarcoma or osteosarcoma or Ewing sarcoma.
Recruitment start: 25 May 2008
Recruitment end: 31 December 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Beatrice Seddon
ARIAD Pharmaceuticals Inc
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 11 December 2014
CRUK internal database number: 1343